Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

Published:2018-04 Issue:1 Volume:5 Page:e000261
ISSN:2053-8790
Container-title:Lupus Science & Medicine
language:en
Short-container-title:Lupus Sci Med

Author:

Riggs Jeffrey M,Hanna Richard N,Rajan Bhargavi,Zerrouki Kamelia,Karnell Jodi L,Sagar Divya,Vainshtein Inna,Farmer Erika,Rosenthal Kimberly,Morehouse Chris,de los Reyes Melissa,Schifferli Kevin,Liang Meina,Sanjuan Miguel A,Sims Gary P,Kolbeck Roland

Funder

MedImmune, LLC

Publisher

BMJ

Subject

Immunology,General Medicine

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-type 1 interferon receptor subunit 1 monoclonal antibody: Anifrolumab;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2024-08-20

2. Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in Systemic Lupus Erythematosus;2024-08-04

3. SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus;Acta Biochimica et Biophysica Sinica;2024-08-01

4. Uso del anifrolumab en el lupus eritematoso sistémico, lupus eritematoso cutáneo y otras dermatosis autoinmunes;Actas Dermo-Sifiliográficas;2024-07

5. Rapid achievement of low disease activity during the use of a type I interferon inhibitor in a patient with torpid systemic lupus erythematosus (case report);Modern Rheumatology Journal;2024-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP